Roadman, D., Abel, E. J., Lotan, P., Risk, M. C., Koehne, E., Kyriakopoulos, C., Emamekhoo, H., Serritella, A. V., Taylor, A., Shapiro, D. D. (2026). Metastatic progression and toxicity in high-risk clear cell renal cell carcinoma patients treated with adjuvant pembrolizumab at a tertiary care center.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.471